On December 31, 2021, Robert S. Swinney notified ICU Medical, Inc. (the ‘Company') of his resignation, effective December 31, 2021 from the Company's Board of Directors (the ‘Board') in accordance with the Board's retirement policy after 24 years of service. Mr. Swinney's decision to retire was not because of any disagreement with the Company's operations policies or practices. On December 31, 2021, the Board elected Ms. Kolleen Kennedy as a new director of the Company, effective December 31, 2021.

The Board determined that Ms. Kennedy qualifies as an independent director within the meaning of the listing requirements of NASDAQ. Ms. Kennedy will stand for election by the Company's stockholders at the 2022 Annual Meeting of Stockholders, which is expected to be held in May 2022. Kolleen Kennedy served as President, Proton Solutions & Growth Office at Varian Medical Systems (‘Varian') from 2018 until December 31, 2021 when she retired.

Ms. Kennedy joined Varian in 1997 as Marketing Manager for radiation therapy delivery systems, and assumed other strategic roles including President of Varian Oncology Systems.